Here's why:
While most property "experts" are telling you to buy negatively-geared houses that COST you money every month...
We at Eastview Advisory have been quietly using a completely different strategy to generate 6-7% net returns on commercial property, with clients creating $400,000+ in instant equity!
No negative gearing.
No maintenance headaches.
No praying your tenant doesn't destroy the property.
Instead, we're using what Fortune 500 companies have known for decades - "The Commercial Property Wealth System" - and we're creating assets where tenants pay ALL expenses while you collect superior returns!
Here's proof it works:
Example 1:
One client bought a commercial building for $1.86 million, signed a lease to his own business, and created $800,000 in equity in one week.
Same building, same location, but now it's worth $2.73 million because it has a tenant!
Example 2:
Another client acquired a $5.5 million childcare center that generates $373,000 per year in rent.
After all expenses (which the tenant pays), he's pocketing over $100,000 annually.
Example 3:
We helped a business owner escape paying $12,000/month in rent by buying his own building for $2.1 million.
He created $350,000 in instant equity and now his "rent" payments go toward an asset he owns!
But here's the problem...
Most Aussie investors have no idea this strategy exists!
And the few who do know about it think it's "too complicated" or confuse it with buying random office buildings without a strategy.
That's exactly why we created this free training.
Simon founded Eastview Advisory in 2022 following a successful corporate career in senior executive roles for multinational businesses (Unilever, ALDI) in Australia, New Zealand and Singapore.
Simon holds a Bachelor of Commerce from the University of Wollongong and a Masters of Property Development (with Distinction) from the University of Technology, Sydney.
A proud family man and Newcastle local, Simon loves to spend his weekends with his wife and three kids making the most of our beautiful coastline.